Gerald Commissiong

Title: The Innovative Mind of Gerald Commissiong

Introduction

Gerald Commissiong, a notable inventor based in Hummelstown, PA, has made significant contributions to the field of neuroprotective treatments through his patented invention. With a focus on methods for protecting sensory cells from death, his work holds promise for improving the quality of life for individuals suffering from sensory cell loss.

Latest Patents

Commissiong holds a patent for a groundbreaking method of administering MANF (mesencephalic astrocyte-derived neurotrophic factor) for the protection of sensory cells. This patent outlines methods for treating or preventing cell death-related sensory cell loss by administering effective amounts of neuroprotective peptides to those in need. Additionally, his patent addresses treatment for drug-induced ototoxicity, offering potential solutions for individuals affected by this condition.

Career Highlights

Throughout his career, Gerald Commissiong has worked with prestigious organizations, including Amarantus Bioscience Holdings, Inc. and the University of Massachusetts. His tenure at these institutions has enabled him to advance his research and innovative methodologies, paving the way for new therapeutics in neurology.

Collaborations

Commissiong has collaborated with esteemed colleagues, such as Lawrence M. Schwartz and David A. Lowe, further enhancing the impact of his work through shared expertise and innovation.

Conclusion

Gerald Commissiong's dedication to exploring neuroprotective therapies illustrates the importance of innovation in advancing medical science. His patent provides a foundation for future research aimed at safeguarding sensory cells, showcasing his commitment to improving health outcomes for those affected by sensory cell-related health issues.